Delivery Order SPE2DB20D7059-SPE2DB25FGSP8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of PREVNAR 20 vaccine in 0.5 mL syringes, valued at $114,520.04 with a firm fixed price and completion date of September 29, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- The Defense Logistics Agency awarded a delivery order valued at $6,926.00 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. Issued on July 29, 2025, with an ultimate completion date of July 30, 2025, this firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $23,429.21 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine procurement under the company's larger relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $7,010.33 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $92,004.02 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitively awarded delivery order carries no set-aside designation and falls under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a $81,688.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for PREVNAR 20 vaccine in 0.5 mL syringes, with completion scheduled for August 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of PREVNAR 20 vaccine in 0.5mL syringes, with a contract ceiling value of $10,730.40. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSP8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PREVNAR 20 vaccine in 0.5mL syringes, valued at $6,535.08 with a completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, demonstrating its capability to meet federal procurement requirements through open competition. This delivery order for pneumococcal vaccine represents one of numerous medical supply deliveries under the broader DLA pharmaceutical prime vendor framework, which is structured to provide flexible access to essential healthcare commodities supporting military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/22/25 |